ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

CTEP Deploys Website To Track Trial Activation

December 10, 2010

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

NCCS Networker Volume 5 Issue 2, Spring 1991

April 13, 1991

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975